{"id":"W2462016111","doi":"10.1093/annonc/mdv522.01","title":"134O RADIANT-4: Efficacy and safety of everolimus in advanced, nonfunctional neuroendocrine tumors (NET) of the lung or gastrointestinal (GI) tract","year":2015,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Clinical endpoint; Everolimus; Internal medicine; Gastroenterology; Population; Placebo; Neuroendocrine tumors; Phases of clinical research; Surgery; Randomized controlled trial; Urology; Clinical trial; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004055543,0.0003603988,0.0007877778,0.0002825659,0.0001351397,0.0003501913,0.000328578,0.0002755144,0.001476379],"category_scores_gemma":[0.0003624418,0.0001401921,0.0005515011,0.0002373801,0.0002971721,0.000459072,0.000153341,0.0009526046,0.0002930125],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003351689,"about_ca_system_score_gemma":0.0003795224,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007975066,"about_ca_topic_score_gemma":0.001356563,"domain_scores_codex":[0.9998537,0.00005577977,0.00001221578,0.00001960801,0.00002188709,0.00003676495],"domain_scores_gemma":[0.9998569,0.00003880233,0.00003106615,0.00001667887,0.000009378297,0.00004706959],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3480301,0.01629256,0.02860173,0.0008978267,0.001608662,0.0007700422,0.0002386051,0.004717275,0.2290374,0.0005630613,0.001893588,0.3673492],"study_design_scores_gemma":[0.05871396,0.5760171,0.2235795,0.0001469046,0.002778024,0.003116672,0.0002340135,0.008076061,0.1114174,0.0004810175,0.01532425,0.0001152895],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9970418,0.001975918,0.0001006064,0.00006174551,0.00002178523,0.00002864032,0.0001158945,0.00001861569,0.0006349963],"genre_scores_gemma":[0.9973716,0.001027579,0.0002057057,0.00005826194,0.00004072606,0.00001911083,0.0003996778,0.00001166039,0.0008655972],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001476379,"threshold_uncertainty_score":0.00493896,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07191084224250151,"score_gpt":0.3917621722105027,"score_spread":0.3198513299680013,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}